Zohar Attias-Geva

发表

Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cells.

H. Werner, D. Ludwig, I. Bentov, 2011, European journal of cancer.

Insulin-like growth factor-I receptor inhibition by speci fi c tyrosine kinase inhibitor NVP-AEW 541 in endometrioid and serous papillary endometrial cancer cell lines

H. Werner, I. Bentov, A. Fishman, 2011 .

p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy.

H. Werner, I. Bentov, A. Fishman, 2012, European journal of cancer.

BRCA1 is Expressed in Uterine Serous Carcinoma (USC) and Controls Insulin-Like Growth Factor I Receptor (IGF-IR) Gene Expression in USC Cell Lines

H. Schayek, H. Werner, D. Kidron, 2012, International Journal of Gynecologic Cancer.

Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in p53-Dependent or -Independent Manners

H. Werner, A. Fishman, Zohar Attias-Geva, 2013, PloS one.

Cancer Genes, Tumor Suppressors, and Regulation of IGF1-R Gene Expression in Cancer

H. Schayek, H. Werner, D. Weinstein, 2012 .

IGF1R-directed targeted therapy enhances the cytotoxic effect of chemotherapy in endometrial cancer.

H. Werner, A. Fishman, Zohar Attias-Geva, 2013, Cancer letters.

The health and economic impact of switching vaccines in universal varicella vaccination programs using a dynamic transmission model: An Israel case study

G. Benčina, C. Burgess, Zohar Attias-Geva, 2022, Human vaccines & immunotherapeutics.

Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines.

H. Werner, I. Bentov, A. Fishman, 2011, Gynecologic oncology.

p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy.

H. Werner, I. Bentov, A. Fishman, 2012, European journal of cancer.

IGF1R-directed targeted therapy enhances the cytotoxic effect of chemotherapy in endometrial cancer.

H. Werner, A. Fishman, Zohar Attias-Geva, 2013, Cancer letters.